Total investments

34

Average round size

72M

Portfolio companies

32

Rounds per year

0.35

Lead investments

6

Follow on index

0.06

Exits

11

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceSoftwareFinTechInformation TechnologyManufacturingMedicalHardwareRenewable EnergySolar

Summary

Nomura Securities appeared to be the Corporate Investor, which was created in 1927. The venture was found in North America in United States. The main department of described Corporate Investor is located in the New York.

We also calculated 1 valuable employee in our database.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Nomura Securities, startups are often financed by JAFCO Japan, Fabrice Grinda, FJ Labs. The meaningful sponsors for the fund in investment in the same round are Sigma Partners, SMBC Venture Capital, Japan Asia Investment. In the next rounds fund is usually obtained by Whiz Partners, Thuja Capital, TIS.

Speaking about the real fund results, this Corporate Investor is 9 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from Nomura Securities is 500 millions - 1 billion dollars. The top amount of exits for fund were in 2006. The top activity for fund was in 2008. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Nomura Securities performs on 5 percentage points less the average number of lead investments.

The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Biotechnology, E-Commerce. Among the most popular portfolio startups of the fund, we may highlight Sosei Group, Acologix, Chroma Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Show more

Investments analytics

Analytics

Total investments
34
Lead investments
6
Exits
11
Rounds per year
0.35
Follow on index
0.06
Investments by industry
  • Software (9)
  • Information Technology (7)
  • Manufacturing (4)
  • Medical (4)
  • Biotechnology (4)
  • Show 57 more
Investments by region
  • Italy (1)
  • United States (11)
  • Canada (1)
  • India (4)
  • Japan (12)
  • Show 4 more
Peak activity year
2018
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
54M
Group Appearance index
0.71
Avg. company exit year
46
Avg. multiplicator
0.35
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
PREVENT 01 Jan 2018 Medical Device, Medical Seed Aichi Prefecture, Nagoya, Japan
Tookitaki 25 Nov 2019 Software, FinTech, Finance, Machine Learning, SaaS, Predictive Analytics, Compliance Early Stage Venture 11M Singapore, Central

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.